โšกToday
โœจToday's leadDoctors Complete First Bone Marrow Transplant From Deceased Donor for Non-Malignant Disease๐ŸŽˆFor kidsSouth Carolina tract beside wildlife refuge to be permanently conserved๐ŸŒฟNatureFormer ocean liner S.S. United States becomes the world's largest artificial reefโšฝSportsLindy Duncan wins her first LPGA title on attempt 222๐ŸŽจCulture & ideasA Lost Altdorfer Landscape Surfaces After 70 Years Privately Held๐Ÿ”ฌScience & healthPeople who control HIV without treatment may help find a cure๐Ÿ’›KindnessA laid-off man began mowing lawns for free and 2,100 volunteers joined๐Ÿ›๏ธPoliticsLos Angeles bans oil drilling after a decade of neighborhood pressure๐Ÿš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

FDA approves Bayer drug to help prevent repeat strokes

STAT 9 November 2026 2 min read

โฎ BeforeBefore: no medicine in this new class was available.
โœ… NowNow: the FDA has approved the drug.

In short

  • The FDA approved the drug, the first in a novel class of medications.
  • It is designed to prevent blood clots without increasing the risk of bleeding.

Why it's good news

People who have had one stroke face a risk of another. This is the first drug in a new class designed to prevent clots without raising bleeding risk. The source gives no trial figures, so the size of the benefit is not yet clear.

Advertisement

From STAT

Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.

Read the full story at STAT Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor